language.en-US
  • EN
  • RU
Shortened Drug Regimens for MDR-TB

The webinar agenda includes:

  • - Welcoming remarks. Dr Askar Yedilbayev, Regional TB and DR-TB Advisor, Joint Infectious Diseases Unit, WHO Regional Office for Europe, Denmark.
  • - mSTR regional operational research: findings and lessons learnt.  Dr Askar Yedilbayev, Regional TB and DR-TB Advisor, and Mr Oleksandr Korotych, Technical Officer, Joint Infectious Diseases Unit, WHO Regional Office for Europe, Denmark. 
  • - endTB clinical trial: overview and outcomes. Dr. Lorenzo Guglielmetti, director of the endTB project.
  • - European TB Research Agenda: implementation status and prospects. Dr Andrei Dadu, medical officer, WHO Regional Office for Europe, Denmark.
  • - Questions and Answers.
1 mSTR OR results (1).pdf 1 Результаты ОИ мКРЛ (1).pdf 2 Results of the endTB trial (1).pdf 2 Результаты исследования endTB (1).pdf 3 European TB Research initiatives (1).pdf 3 Инициативы ЕРБ-ВОЗ (1).pdf